Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06463613 · ClinicalTrials.gov registry record · NA

Using a Novel Skin Tag Removal Device

A NA study of Achrochordon, sponsored by UK Innovations GP.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06463613 is a NA study of Achrochordon that is active but no longer recruiting, run by UK Innovations GP. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06463613, a NA study of Achrochordon, is active but no longer recruiting, sponsored by UK Innovations GP.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to investigate the use of a mechanical device to remove skin tags in adults. The device ("Skin Tag Removal", or STR) utilizes the ligation method by applying a silicone band around the base of a skin tag, therefore restricting the blood supply, which is vital to its growth and survival. Because this method does not include freezing or burning of tissue in or around the skin tag, it could be considered less invasive and less risky than other options.

Conditions Studied

Interventions

  • DEVICE STR Skin Tag Removal device with diary and follow-up

Study Locations (1)

California

  • Center for Dermatology Clinical Research, Inc. - Fremont

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-06-03
Est. Completion 2026-01-07
Phase NA

Sponsor

UK Innovations GP

1 total trials

What the Registry Record Tells You About NCT06463613

The ClinicalTrials.gov registry entry for NCT06463613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UK Innovations GP, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Achrochordon appearing as the primary indexed condition, and to 1 intervention - of which STR Skin Tag Removal device with diary and follow-up is the first listed.

NCT06463613 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06463613 about?

NCT06463613 is a clinical study titled "Using a Novel Skin Tag Removal Device". The aim of this study is to investigate the use of a mechanical device to remove skin tags in adults. The device ("Skin Tag Removal", or STR) utilizes the ligation method by applying a silicone band around the base of a skin tag, therefore restricting the blood supply, which is vital to its growth ...

What is the current status of trial NCT06463613?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-03. Estimated completion is 2026-01-07.

What conditions does trial NCT06463613 study?

This clinical trial studies the following conditions: Achrochordon.

What interventions are being tested in trial NCT06463613?

The interventions under investigation include: STR Skin Tag Removal device with diary and follow-up (DEVICE).

Who is sponsoring clinical trial NCT06463613?

This trial is sponsored by UK Innovations GP, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06463613 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.